• John M. Collins

    John M. Collins

    Chief Operating Officer and Technology Implementation Director at CIMIT

    Before joining CIMIT, John M. Collins was president of TIAX LLC, a 200-person technology transformation company and, before that, Senior Vice President at Arthur D. Little Inc. managing its 250-person Technology and Innovation business. He has spent his career in industry as a leader in technology-driven businesses, with more than 30 years of international experience focused on the accelerated development and commercialization of innovative technology, products and services.

  • Fabienne Berthet

    Fabienne Berthet

    Innovation Management and Business Development in Healthcare at Savoir-Faire & Cie, SA

    Fabienne manages consulting missions in strategy and innovation within biotech, high-tech companies, business clusters, and investment organizations in Healthcare. She is enabling both traditional biotech/pharma and digital health business models. She is also a business angel and member of scientific or strategic boards of start-ups.

  • Meike Bomhof

    Meike Bomhof

    Senior Associate in Europe, HullAssociates Ltd

    Meike Bomhof is the Senior Associate in Europe at HullAssociates Ltd., a Global Market Access and Reimbursement Consultancy. Since its inception in 2007 she has assisted with the growth of the company in Europe to its present size and provided market access and reimbursement strategy & implementation support related to a wide variety of innovative medical devices mostly in Spain, Italy and The Netherlands.

  • Elena Canetti

    Elena Canetti

    Managing Partner at Inveniam Group

    Elena is one of EMEA’s most experienced tech transfer executives, having completed hundreds of license and research deals in different industries. Prior to co-founding Inveniam, Elena served as VP of Technology Transfer at Marqera LLC, as VP for R&D Collaborations at Hebrew University in Jerusalem, was Manager at Razei Bar (nutraceuticals), and Marketing Manager at Orgenics (diagnostics). Elena holds an MBA Boston University and BFA Tel Aviv University.

  • Marshall Collins

    Marshall Collins

    CRAASH Manager and a Research Analyst at CIMIT

    Marshall Collins has background in Economics and Behavioral Neuroscience. He also works on the ongoing development and support of the cloud-based online platform CoLab, which supports collaborative teams in navigating some portion of the innovation cycle. Over the past few years, CoLab has been adopted domestically to be used by Yale and Texas Children’s Hospital, as well as internationally, with portals in the UK, Singapore, and others.

  • Dominique Delmas

    Dominique Delmas

    Chief Executive Officer at Futurs Health Products

    Dominique Delmas (VMD, MBA) have been acting as a Senior Consultant in Medical Devices Innovation Management and Business Development for many years. After 10 years spent in International Drugs Development as Clinical Development Director (Phase 1 to 3 - C.R.I.S CRO, France), she got the opportunity to work for transferring Thomson-CSF (Thales) Technologies to Health Sector.

  • Mike Dempsey

    Mike Dempsey

    Entrepreneur in Residence at CIMIT and leader of the CIMIT Accelerator

    He has been working in the field of medical devices for more than 25 years. Over this time, he has invented or worked on products that have treated more than twenty million people. Dempsey has helped develop and introduce dozens of successful products, holds over 40 patents in wireless medical device communications and has ten more patents pending. He was a co-founder of Radianse and worked for Philips Medical Systems.

  • Eric J. Evans

    Eric J. Evans

    Executive Committee at Mass Medical Angels and Screening Committee of Launchpad Ventures

    An active member of the early-stage investment community in Boston, Evans sits on the Executive Board of Mass Medical Angels and on the Screening Committee of Launchpad Ventures. He also maintains relationships with Hub Investment Group, Boston Harbor Angels and Cherrystone, among others. He has served as CEO for several biomedical companies, including Targeted Cell Therapies, Abazyme, Lumos Catheter Systems, Mulleris Therapeutics and Follica Biosciences.

  • Wolfgang Krull

    Wolfgang Krull

    Senior Operations Management Professional in the Medical Device Industry

    Krull has a proven track record of leading complex business, site, operations, supply chain and product development organizations, including two successful start-ups. His specialties include leading operations, strategic planning, organizational development, and program management to meet worldwide business, quality, and regulatory requirements. He spent 24 years with Hewlett Packard Medical (now Philips) before joining two start-ups that were later acquired by General Electric and Medtronic.

  • Andrés Montefeltro

    Andrés Montefeltro

    Senior Vice President, Research Head & Founder at nLifeTherapeutics

    Dr. Montefeltro is responsible for preclinical oligonucleotide drug discovery and oligonucleotide technology research. Dr. Montefeltro has published papers in the field of antisense research and development and has issued the foundational nLife patents at U.S. and E.U. He started his entrepreneurial career in 1996 launching a technology based consulting firm, Amtec.net.

  • Paul Tessier

    Paul Tessier

    Co-founder of Radianse and founder of Technology Innovators

    Tessier is an experienced medical device developer, manager and entrepreneur. He is a co-founder of Radianse and the founder of Technology Innovators, a company that researches specific medical problems, invents solutions, prototypes and patents the solutions and finally licenses the technology to others. He worked at Philips Medical and also held various leadership positions in marketing and R&D for a diverse set of healthtech products.

  • Josh Tolkoff

    Josh Tolkoff

    CIMIT Accelerator Executive

    Tolkoff has over thirty years of experience in research, development, manufacturing, regulatory affairs and general management of medical device companies. He is recognized as a leading figure in the Massachusetts medical device community and serves on the board of several private companies. After a research position at Mass General Hospital, Josh started his commercial career at Medi-Tech and helped grow that company from 20 to 500 employees. He has founded several start-ups including ACT Medical, built to over $25 millions in sales.

  • Inma Valle

    Inma Valle

    CEO at MetaboStem

    Inma Valle worked as Independent Advisor and Investor in the Biotechnology sector. She was Investment Manager at Caixa Capital Risc, the venture arm of La Caixa, were she lead more than 10 investments in the Life Sciences Sector and sat as Board Member at 4 biotechnology companies. Previously, she spent 4 years working as a researcher at the Diabetes Center at UCSF, where she focused on central regulation of metabolic disorders (obesity, type 2 diabetes, etc).

  • Joel Weinstein

    Joel Weinstein


    President at MAVEN Medical Device Strategies

    Weinstein is a serial entrepreneur and an industry-recognized marketing and strategy “guru” in medical imaging and women’s health. He was a member of the founding management team of Hologic, Inc. and directed the strategies over that company’s first 12 years of meteoric growth. He has held different founding and management positions at Assurance Medical, VueSonix Sensors, Andrew Technologies, BioSphere Medical, MassMEDIC and MAVEN Medical Device Strategies. He has served on several FDA working groups.

  • Anders Westermark

    Anders Westermark

    Physician at the Department of Surgical Sciences, Orthopaedics

    Anders Westermark is a board-certified specialist in orthopedic surgery since 2011 and a Clinical Innovation Fellow. The contact with the Innovation Fellowship program has continued in the form of mentorship. Currently, he is pursuing projects in hospital pharmaceutical supply chain management, biomaterials for bone healing (PhD project) and development of trauma injury immobilization products (small company together with two others

  • Markus Wilhelms

    Markus Wilhelms

    Chief Executive Officer at MOWOOT (USMIMA)

    Markus has a Ph.D. degree in Molecular Biology and is fellow of the first edition of MOEBIO Design health Barcelona (EIT Health and Stanford Biodesign affiliated). He co-founded the medical device company MOWOOT in 2014 and launched their first product to treat chronic constipation in 2016. Markus has the first-hand experience in early-stage fundraising, market entry, and team leadership and has won various international pitch competitions & awards for MOWOOT.